1Forst T, Kunt T, Pohlmann T, et al. Biological activity of C-peptide on the skin microcirculation in patients with insulin dependent diabetes mellitus[ J ]. J Clin Invest, 1998, 101 ( 10 ) : 2036-2041.
2Kunt T, Schneider S,Pfutzner A, et al. The effect of human proinsulin C-peptide on erythrocyte deformability in patients with type 1 diabetes mellitus[ J]. Diabetologia, 1999,42 ( 4 ) : 465-471.
3Ohtomo Y, Aperia A, Sahlgren B, et al. C-peptide stimulates rat renal Na^+ -K^+ -ATPase activity in synergism with neuropeptide Y[J]. Diabetologia, 1996,39(2) :199-205.
4Tsimaratos M, Roger F, Chabardes D, et al. C-peptide stimulates Na^ + -K^+ -ATPase activity via PKC alpha in rat medullary thick ascending limb [J ]. Diabetologia, 2003,46 ( 1 ) : 124 - 131.
5Ido Y, Vindigni A i Chang K, et al. Prevention of vascular and neural dysfunction in diabetie rats by C-peptide[J].Sience, 1997. 277(5325) : 563-566.
6Shafqat J,Juntti-Berggren L, Zhoug Z, et al. Proinsulin C-peptide and its analogues induce intracellular Ca^2 + increases in human renal tubular cells [ J] . Cell Mol Life Sci, 2002,59 ( 7 ) : 1185-1189.
7Kunt T, Forst T, Closs E, et al. Activation of endothelial nitric oxide synthase (eNOS) by C-peptide[J]. Diabetologia, 1998,41 [ Suppl 1 ] :A176.
8Johansson BL,Wahren J, Pernow J. C-peptide increases forearm blood flow in patients with type I diabetes via a nitric oxide-dependent mechanism[ J] .Am J Physiol Endocrinol Metab,2003,285(4):E864-870.
9Forst T, Dufayet D, Kunt T, et al. Effects of proinsulin C-peptide on nitric oxide, microvascular blood flow and erythrocyte Na^+ - K^+ - ATPase activity in diabetes mellitus type [J]. Clin Sci ,2000,98(3) :283-290.
10Ringer R, Pramanik A, Jonasson P, et al. Specific binding of proinsulin C-peptide to human cell membranes [J]. Proc Natl Acad Sci USA,1999,96(23) : 13318-13323.
二级参考文献2
1R. Rasch,J. D?rup. Quantitative morphology of the rat kidney during diabetes mellitus and insulin treatment[J] 1997,Diabetologia(7):802～809
